Northern Trust’s BioCardia BCDA Stock Holding History

Northern Trust’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,282	Closed	-$7.83K	–	4417
2024 Q1	$7.83K	Hold	1,282	–	–	﹤0.01%	4398
2023 Q4	$12.8K	Hold	1,282	–	–	﹤0.01%	4404
2023 Q3	$8.27K	Hold	1,282	–	–	﹤0.01%	4410
2023 Q2	$51.3K	Hold	1,282	–	–	﹤0.01%	4220
2023 Q1	$37.5K	Hold	1,282	–	–	﹤0.01%	4322
2022 Q4	$40.2K	Hold	1,282	–	–	﹤0.01%	4335
2022 Q3	$37K	Hold	1,282	–	–	﹤0.01%	4403
2022 Q2	$28K	Hold	1,282	–	–	﹤0.01%	4566
2022 Q1	$40K	Hold	1,282	–	–	﹤0.01%	4577
2021 Q4	$37K	Hold	1,282	–	–	﹤0.01%	4638
2021 Q3	$60K	Hold	1,282	–	–	﹤0.01%	4503
2021 Q2	$76K	Hold	1,282	–	–	﹤0.01%	4418
2021 Q1	$83K	Buy	1,282 +84	+7%	+$5.25K	﹤0.01%	4309
2020 Q4	$62K	Buy	+1,198	New	+$47.9K	﹤0.01%	4205

Other funds holding BCDA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Pingora Partners Wilson, Wyoming $169M AUM 56.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust's BCDA Position: Q2 2024 in Review

Northern Trust sold out of BioCardia (BCDA) in Q2 2024, closing a stake of 1,282 shares — an estimated $7.83K sold.

Northern Trust first reported a position in BCDA in Q4 2020 and held it in 14 quarters. The position peaked at $83K in Q1 2021. 10 funds tracked by Wall St. Rank hold BCDA as of Q2 2024.

Northern Trust reported no remaining BioCardia position as of Q2 2024 after selling out during the quarter.
Northern Trust sold 1,282 BioCardia shares in Q2 2024, an estimated $7.83K.
Northern Trust first reported a position in BioCardia in Q4 2020 and held it in 14 quarters.
Northern Trust's BioCardia position peaked at $83K in Q1 2021.
10 funds tracked by Wall St. Rank held BioCardia as of Q2 2024.

Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.